126 related articles for article (PubMed ID: 4258017)
1. Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors.
DeWys WD
Cancer Res; 1972 Feb; 32(2):374-9. PubMed ID: 4258017
[No Abstract] [Full Text] [Related]
2. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
3. A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.
DeWys WD
Cancer Res; 1972 Feb; 32(2):367-73. PubMed ID: 5058192
[No Abstract] [Full Text] [Related]
4. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.
Yuhas JM; Pazmino NH; Proctor JO; Toya RE
Cancer Res; 1974 Apr; 34(4):722-8. PubMed ID: 4360837
[No Abstract] [Full Text] [Related]
5. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
Mayo JG
Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
[No Abstract] [Full Text] [Related]
6. Lewis lung carcinoma in mice as an experimental therapy model. I. The growth kinetics and the effect of tumor on host.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):363-72. PubMed ID: 7184487
[TBL] [Abstract][Full Text] [Related]
7. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
8. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
Isakov N; Feldman M; Segal S
Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
[TBL] [Abstract][Full Text] [Related]
9. Unusual sites of lung tumor metastases in B6C3F1 mice and F344 rats.
Reznik G
Anticancer Res; 1981; 1(3):159-62. PubMed ID: 7342855
[TBL] [Abstract][Full Text] [Related]
10. Transplantability and biological behavior of mouse liver tumors induced by ethylnitrosourea.
Kyriazis AP; Vesselinovitch SD
Cancer Res; 1973 Feb; 33(2):332-8. PubMed ID: 4347468
[No Abstract] [Full Text] [Related]
11. Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure.
Pál K; Kopper L; Lapis K
Invasion Metastasis; 1983; 3(3):174-82. PubMed ID: 6677625
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of experimental metastasis by x-ray: a possible mechanism.
Fidler IJ; Zeidman I
J Med; 1972; 3(3):172-7. PubMed ID: 4508256
[No Abstract] [Full Text] [Related]
13. Syngeneic serum and ascitic fluid in enzymatically produced tumour cell suspensions. II. Effects on experimental metastases.
Boeryd B; Knutson F; Lundin PM; Norrby K
Pathol Eur; 1971; 6(1):43-9. PubMed ID: 5550665
[No Abstract] [Full Text] [Related]
14. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N
Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246
[TBL] [Abstract][Full Text] [Related]
15. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.
Liotta LA; Kleinerman J; Saidel GM
Cancer Res; 1974 May; 34(5):997-1004. PubMed ID: 4841969
[No Abstract] [Full Text] [Related]
16. Hematogenous dissemination of tumour cells and metastases formation in Ehrlich ascites tumour.
Kiseleva NS; Magamadov YC
Neoplasma; 1972; 19(4):257-75. PubMed ID: 5054530
[No Abstract] [Full Text] [Related]
17. [Chemotherapeutic responses of a primary tumor and its pulmonary metastases in murine tumor systems in relation to its proliferative properties].
Ohno K
Osaka Daigaku Shigaku Zasshi; 1984 Jun; 29(1):64-85. PubMed ID: 6590823
[No Abstract] [Full Text] [Related]
18. Teratoma: a model for studying cancer biology.
Thompson DK
J Maine Med Assoc; 1974 Sep; 65(9):201-4. PubMed ID: 4416069
[No Abstract] [Full Text] [Related]
19. Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition.
Qadri SS; Wang JH; Coffey JC; Alam M; O'Donnell A; Aherne T; Redmond HP
Ann Thorac Surg; 2005 Mar; 79(3):990-5; discussion 990-5. PubMed ID: 15734421
[TBL] [Abstract][Full Text] [Related]
20. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
Milas L; Hunter N; Mason K; Withers HR
Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
